Loading clinical trials...
Loading clinical trials...
A 12 Month, Single-center, Non-randomized, Open-label Study of Outcomes of Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores in de Novo Renal Transplant Recipients
Conditions
Interventions
Belatacept
Locations
1
United States
University of Maryland
Baltimore, Maryland, United States
Start Date
March 1, 2012
Primary Completion Date
February 28, 2017
Completion Date
March 1, 2018
Last Updated
June 14, 2018
NCT04634916
NCT06933472
NCT07224763
NCT07033260
NCT05738525
NCT06373575
Lead Sponsor
University of Maryland
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions